Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Standard Biotools (LAB) Current Taxes (2022 - 2023)

Historic Current Taxes for Standard Biotools (LAB) over the last 2 years, with Q4 2023 value amounting to $1.2 million.

Standard Biotools' Current Taxes fell 1476.09% to $1.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year decrease of 1476.09%. This contributed to the annual value of $1.2 million for FY2023, which is 1476.09% down from last year.
Standard Biotools' Current Taxes amounted to $1.2 million in Q4 2023, which was down 1476.09% from $1.1 million recorded in Q3 2023.
Standard Biotools' Current Taxes' 5-year high stood at $1.4 million during Q4 2022, with a 5-year trough of $1.1 million in Q3 2023.